Abstract Submission Guidelines & Instructions
Biomed Israel 2023 Conference Program is expanding the scope and range of topics to explore trends and innovations which are shaping the future of the healthcare system to its full extent. Each topic will consist of Invited Lectures/Panels and Company Presentations.
Companies are invited to submit an abstract to be reviewed for oral presentation in the Company Presentation Sessions of Biomed Israel 2023.
Please ensure you read the Abstract Submission Guidelines & Instructions thoroughly prior to submission.
Presenting authors must hold one of the following positions: Chairman of the BOD, CEO, CFO, COO, CSO, VP of Business Development, VP of R&D, General Manager.
The Registration Fee for presenters of abstracts accepted to Company Presentation Sessions, will be covered for the day of the presentation and presenters will be automatically registered to the Conference. If the presenter wishes to attend the conference on any of the other 2 days, then on-line registration for any additional days must be completed.
Submission Category and Presentation Type
Abstracts for Oral Company Presentations in the Biomed Israel 2023 Conference Program must be submitted for a specific Submission Category and a specific Presentation Type. In all tracks we will feature Medical Device, Biopharma, Digital Health and Diagnosis, where appropriate.
- Submission Category (Mandatory to select one):
Accepted abstracts will be scheduled in the relevant Conference Program Track.
- Longevity - How to Complete the Centenarian Decathlon?
- Do we Know Enough About the Brain to Treat Neurological Disorders?
- Are Cancer Therapeutics Fulfilling the Promise?
- Can we Successfully Diagnose and Guide Patients' Optimal Cancer Treatment?
- AI Tapestry: Optimizing the Interaction of AI and Biopharma
- Facts and Myths on Ex-Liver Drug Delivery and New Horizons to Cure Rare Disorders
- Patients are Consumers at Home – How Far Can They Manage Their Health?
- Robots Dancing with Humans in the Healthcare Systems and Homes
- Are Medical Devices Still Relevant in the Context of New Biology?
- Let Food be Thy Medicine and Medicine be Thy Food
- How do we make Academic Translation Medicine replicable and relevant?
- Bio- Convergence - Everything That Rises Must Converge
- Skin Health and Beauty
- Presentation Type (Mandatory to select one):
- Biotech/Pharma
- Medical Devices
- Health IT/Digital Health
- Bio Food
- Bio Convergence
- Service Providers
Abstract Template Instructions
- The Company Presentation Abstract takes the format of QUESTIONS AND RESPONSES, submitted abstracts will be evaluated on the ANSWERS to the questions. Do NOT include any other text in the document.
- Complete the abstract and save it to your computer.
- NOTE: Abstracts must be saved as a Word “*.doc” file and NOT a “*.docx” file.
- Select the Submission Category (tracks) and Presentation Type relevant to your company, i.e. Biotech/Pharma or Medical Devices or Health IT/Digital Health or Bio Food or Bio Convergence or Service Providers.
- Answers should not exceed 60 words per question.
- The minimum number of words is 100 and the maximum number of words used should not exceed 400.
- After answering the questions, leave the main bullets and delete the explanation text under each bullet.
- The abstract will now be ready for upload to the submission system.
Abstract Questions
The following questions should be answered on the abstract template. Answers should not exceed 60 words per question.
- Investment Rational
Briefly describe the company’s technology or therapeutic focus; the market opportunity, progress made to date, key partnerships or joint ventures; and management strengths. - Business Strategy
Briefly describe how the company will apply its core technology.
Generate near-term and long term revenues. - Core Technology
What is the technology, its uniqueness and its value proposition? - Product Profile/Pipeline
Describe companies’ product/pipelines, current status and market potential. Discuss milestones, potential collaboration and partnership. - What’s Next?
R&D
Preclinical / Clinicals
Organizational Plans
Financial Plans
The following questions should be answered on the abstract template. Answers should not exceed 60 words per question.
- Main Service
Briefly describe the company’s services and therapeutic areas (e.g. regulation, reimbursement, IP, etc). - Key Strengths
What is the uniqueness and key value proposition, management experience, etc? - Experience with Israeli Companies
If relevant, please provide examples. - Key Markets
In which territories are your expertise and services relevant?
For Abstract queries – please contact:
Ms. Phillipa Friedland
Office: +972-74-745-7493
Email: [email protected]